On May 9, 2025, UBS analyst Manav Gupta maintained a "Buy" rating for Aemetis (AMTX, Financial) while lowering the company's price target. The new price target is set at $2.20 USD, a decrease from the previous target of $2.50 USD.
The adjustment represents a 12% reduction in the price target for Aemetis (AMTX, Financial). Despite the lowered target, the "Buy" rating suggests continued confidence in the stock's potential growth.
Investors should note that the updated price target reflects UBS's latest assessment of Aemetis's (AMTX, Financial) financial outlook amidst current market conditions. The stock remains a "Buy" according to the UBS analyst report.
Aemetis (AMTX, Financial) continues to capture investor interest due to its developments in renewable fuels and biotechnology, with UBS's analyst providing ongoing guidance for stakeholders.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for Aemetis Inc (AMTX, Financial) is $10.60 with a high estimate of $28.00 and a low estimate of $1.50. The average target implies an upside of 721.71% from the current price of $1.29. More detailed estimate data can be found on the Aemetis Inc (AMTX) Forecast page.
Based on the consensus recommendation from 6 brokerage firms, Aemetis Inc's (AMTX, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Aemetis Inc (AMTX, Financial) in one year is $7.29, suggesting a upside of 465.12% from the current price of $1.29. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Aemetis Inc (AMTX) Summary page.
